EXAS

Exact Sciences Corporation

Halal Rating :
Comfortable
Last Price $59.35 Last updated:
Market Cap $11.4b
7D Change -3.1%
1 Year Change -16.91%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Healthcare
  • Services – Health
Exchange NASDAQ
Next Earnings Date Oct. 30, 2024

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of cancer. The company's flagship product is Cologuard, a non-invasive screening test for colorectal cancer. They also offer Oncotype DX tests for breast, colon, and prostate cancers, which help inform treatment decisions.

The company develops and commercializes cancer screening and diagnostic tests that help improve patient outcomes through early detection and optimized treatment decisions.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $708.65m $757.66m - $9.61m 0.00% 1.27%
June 30, 2024 $699.26m $725.41m - $-111000.0 0.00% 0.02%
March 31, 2024 $637.52m $752.16m - $7.94m 0.00% 1.06%

Company Impact

Help us evaluate Exact Sciences Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates